TABLE 2.
Distribution of variants of the gH, gL, and gO genes coding for the gCIII complex in clinical isolates and laboratory strains of human CMV
| gL variant | No. of isolates (plus laboratory strain) with gH1 and gO variant:
|
No. of isolates (plus laboratory strain) with gH2 and gO variant:
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1a | 2 | 3 | 4 | Mix | 1a | 2 | 3 | 4 | Mix | |
| 1 | 8 (AD169) | 1 | 1 | 0 | 3 | 1 | 2 | 0 | 0 | 3 |
| 2b | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 (Towne) | 0 |
| 3 | 12 (Toledo) | 4 | 1 | 1 | 4 | 1 | 3 | 6 | 1 | 2 |
| 4 | 13 | 0 | 5 | 3 | 0 | 0 | 7c | 6 | 1 | 3 |
| Mix | 3 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 1 |
a
P = 0.00001 when the frequency of the association of gO1 with gH1, irrespective of the gL variant, was compared to that with gH2.
b
P = 0.01 when the frequency of gL2 association with any gO variant within the gH1 variant group was compared to that of any other gL variant.
c
P = 0.03 when the frequency of gO2-gL4 in the gH2 variant group was compared with that in the gH1 variant group.